Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Death; Vomiting; Cardiac arrest; This is a spontaneous report from a contactable consumer downloaded from the regulatory authority-WEB (GR-GREOF-20212525). An 81-year-old female patient received the first dose of BNT162B2 (COMIRNATY), intramuscularly, on 01Apr2021 as a single dose for COVID-19 immunisation. Medical history included chronic obstructive pulmonary disease (started 4 decades ago) and dementia from 2019. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included quetiapine fumarate (QUEPIN) from 09Sep2020 to 13Apr2021. The patient previously received the influenza vaccination (MANUFACTURER UNKNOWN) for immunisation in Nov2020. The patient experienced death, vomiting, and cardiac arrest on 14Apr2021, reported as medically significant and fatal. The patient died on 14Apr2021. The cause of death was reported as cardiac arrest. An autopsy was not performed. No follow-up attempts are possible; information about batch number cannot be obtained.; Reported Cause(s) of Death: Cardiac arrest
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166